Delistment of Piperacillin + Tazobactam Preparations in the Government Mediated Access Price (GMAP) List. Click the link to know more regarding the advisory.
Duterte Legacy Summit highlights DOH efforts on setting Maximum Retail Price for high-cost medicines
The DOH Pharmaceutical Division expresses its gratitude to the leadership and concern for poor and vulnerable Filipino patients shown by President Rodrigo Duterte with the passage of two landmark Executive Orders which set maximum retail price to 120 high cost medicines.
DOH Announces Full Implementation of Drug Price Caps with Executive Order No. 155
The Department of Health (DOH) announces the full implementation of drug price caps starting March 23, 2022 through Executive Order (EO) No. 155 signed by President Rodrigo Duterte. This brings the total number of drugs with maximum drug retail price to 121 molecules or 204 drug formulas, following the first round of price regulation implemented in June 2020 with the signing of EO No. 104 which covered 87 molecules.
Standard Information, Education and Communication (IEC) Materials for the Implementation of Maximum Drug Retail Price through Executive Order No. 155 s. 2021
The Executive Order (EO) No. 155, “Further Improving Access to Healthcare Through the Regulation of Prices in the Retail of Drugs and Medicines,” which was issued by President Rodrigo R. Duterte on 07 December 2021, subjected 34 drug molecules or 71 drug formulas under price regulation through Maximum Wholesale Price (MWP) and Maximum Retail Price (MRP). The implementation shall begin on 23 March 2022.
DOH Lauds New Price Caps on Medicines
The Department of Health expressed elation over the signing of Executive Order (EO) No. 155, by President Rodrigo Roa Duterte adding 34 medicines to the list of drugs with mandatory price caps.
Adjustments in Maximum Retail Price (MRP) Regulation of Certain Medicines that are Covered by Executive Order No. 155 Pursuant to Exemption from Value Added Tax (VAT)
DOH informs the public of the adjustments in the Maximum Retail Price (MRP) of certain medicines that are covered by EO 155
(Department Circular No. 2022-0046) Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations
Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations Related Posts Maximum Retail Price of Drugs and Medicines 14 Sep 2020 (Executive Order #155) Further Improving Access to Healthcare continue reading : (Department Circular No. 2022-0046) Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations
(Department Circular No. 2021-0575) Effectivity of Executive Order No. 155 “Further Improving Access to Healthcare Through the Regulation of Prices in the Retail of Drugs and Medicines”
Effectivity of Executive Order No. 155 “Further Improving Access to Healthcare Through the Regulation of Prices in the Retail of Drugs and Medicines” Related Posts Maximum Retail Price of Drugs continue reading : (Department Circular No. 2021-0575) Effectivity of Executive Order No. 155 “Further Improving Access to Healthcare Through the Regulation of Prices in the Retail of Drugs and Medicines”
(Executive Order No. 155) Further Improving Access to Healthcare through the Regulation of Prices in the Retail of Drugs and Medicines
President Duterte inks executive order on new price cap of essential medicines
Access the full document Here
Recommendation to Subject Certain Medicines Used in the Treatment of COVID-19 Under Maximum Retail Price
ADVISORY October 25, 2021 RECOMMENDATION TO SUBJECT CERTAIN MEDICINES USED IN THETREATMENT OF COVID-19 UNDER MAXIMUM RETAIL PRICE On 10 September 2021, Proclamation No. 1218 extended the State continue reading : Recommendation to Subject Certain Medicines Used in the Treatment of COVID-19 Under Maximum Retail Price